1. 2622 A Phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC). (September 2015) Authors: McDermott, D.F.; Infante, J.R.; Chowdhury, S.; Voss, M.H.; Motzer, R.J.; Perini, R.F.; Morosky, A.; Zheng, F.F.; White, B.C.; Wang, Q.; Jewell, R.C.; Rini, B.I. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 501 Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial. (September 2015) Authors: George, S.; Motzer, R.J.; Hammers, H.; Redman, B.; Kuzel, T.; Tykodi, S.S.; Plimack, E.; Jiang, J.; Waxman, I.; Rini, B.I. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR). (February 2017) Authors: Schmidinger, M.; Motzer, R.J.; Powles, T.; Escudier, B.; Tannir, N.M.; Mainwaring, P.N.; Rini, B.I.; Hammers, H.J.; Donscov, F.; Roth, B.; Peltola, K.; Lee, J.L.; Heng, D.Y.C.; Aftab, D.T.; Hessel, C.; Scheffold, C.; Schwab, G.; Pal, S.; Hutson, T.E.; Choueiri, T.K. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗